Takehisa Kitazawa

3.1k total citations
52 papers, 1.8k citations indexed

About

Takehisa Kitazawa is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Takehisa Kitazawa has authored 52 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 15 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Takehisa Kitazawa's work include Hemophilia Treatment and Research (30 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Platelet Disorders and Treatments (18 papers). Takehisa Kitazawa is often cited by papers focused on Hemophilia Treatment and Research (30 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Platelet Disorders and Treatments (18 papers). Takehisa Kitazawa collaborates with scholars based in Japan and United States. Takehisa Kitazawa's co-authors include A P Somlyo, Midori Shima, Tetsuhiro Soeda, Bruce D. Gaylinn, Kunihiro Hattori, Keiji Nogami, Tomoyuki Igawa, Yoshiki Kawabe, Kazutaka Yoshihashi and Avril V. Somlyo and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Takehisa Kitazawa

49 papers receiving 1.7k citations

Peers

Countries citing papers authored by Takehisa Kitazawa

Since Specialization

Citations

This map shows the geographic impact of Takehisa Kitazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehisa Kitazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehisa Kitazawa more than expected).

Fields of papers citing papers by Takehisa Kitazawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takehisa Kitazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehisa Kitazawa. The network helps show where Takehisa Kitazawa may publish in the future.

Co-authorship network of co-authors of Takehisa Kitazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Takehisa Kitazawa. A scholar is included among the top collaborators of Takehisa Kitazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehisa Kitazawa. Takehisa Kitazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insights from in vitro global assays on possible doses of concomitant hemostatic agents in the presence of NXT007 in hemophilia A 2025 ·Journal of Thrombosis and Haemostasis ·Kenichi Ogiwara, Shoko Furukawa, (unknown), (unknown), Yuto Nakajima, (unknown), Takehisa Kitazawa, Keiji Nogami	0
2	Development of a novel postoperative adhesion induction model in cynomolgus monkeys with high reliability and reproducibility 2025 ·Scientific Reports ·(unknown), Masaki Yamazaki, Hiromi Tanimura, (unknown), (unknown), (unknown), (unknown), Ayako Nishimoto, Atsuhiko Kato, Takehisa Kitazawa, Ryo Konno, Tadashi Sankai	1
3	773 SOF10, selectively blocking latent TGF-β1 activation, potentiates the efficacy of checkpoint blockade therapy by modulating CAF dynamics and T cell infiltration 2024 ·Regular and Young Investigator Award Abstracts ·(unknown), (unknown), (unknown), Shao‐Cong Sun, (unknown), Hiroki Kawauchi, Yoko Kayukawa, Saori Matsuo, (unknown), (unknown), Takehisa Kitazawa, Tomoyuki Igawa, (unknown)	1
4	Reduced plasma factor X is associated with a lack of response to recombinant activated factor VII in patients with hemophilia A and inhibitor, but does not impair emicizumab-driven hemostasis in vitro 2024 ·Thrombosis Research ·Koji Yada, (unknown), Kenichi Ogiwara, Tetsuhiro Soeda, Takehisa Kitazawa, Keiji Nogami	2
5	Determination of starting dose of the T cell-redirecting bispecific antibody ERY974 targeting glypican-3 in first-in-human clinical trial 2022 ·Scientific Reports ·Shunichiro Komatsu, Yoko Kayukawa, Yoko Miyazaki, Akihisa Kaneko, (unknown), Takahiro Ishiguro, (unknown), Werner Frings, (unknown), Kiyoaki Sakata, Toshihiko Fujii, Shohei Kishishita, Takehisa Kitazawa, Mika Endo, Yuji Sano	10
6	Activated factor VIII-mimicking effect by emicizumab on thrombus formation in type 2N von Willebrand disease under high shear flow conditions 2020 ·Thrombosis Research ·(unknown), (unknown), Takehisa Kitazawa, Midori Shima, Keiji Nogami	6
7	An anti‐factor IXa/factor X bispecific antibody, emicizumab, improves ex vivo coagulant potentials in plasma from patients with acquired hemophilia A 2020 ·Journal of Thrombosis and Haemostasis ·Masahiro Takeyama, Keiji Nogami, Tomoko Matsumoto, (unknown), Takehisa Kitazawa, Midori Shima	20
8	Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI‐deficient plasma in vitro 2018 ·Journal of Thrombosis and Haemostasis ·(unknown), Keiji Nogami, Koji Yada, Kenichi Ogiwara, Shoko Furukawa, Tetsuhiro Soeda, Takehisa Kitazawa, Midori Shima	12
9	Emicizumab‐mediated haemostatic function in patients with haemophilia A is down‐regulated by activated protein C through inactivation of activated factor V 2018 ·British Journal of Haematology ·Koji Yada, Keiji Nogami, (unknown), Takehisa Kitazawa, Kunihiro Hattori, Kagehiro Amano, Katsuyuki Fukutake, Midori Shima	14
10	Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti‐factor IXa/factor X bispecific antibody emicizumab 2018 ·Journal of Thrombosis and Haemostasis ·Keiji Nogami, Tomoko Matsumoto, (unknown), Tetsuhiro Soeda, Nobuo Arai, Takehisa Kitazawa, Midori Shima	79
11	Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody 2018 ·PLoS ONE ·Zenjiro Sampei, Kenta Haraya, Tatsuhiko Tachibana, Taku Fukuzawa, (unknown), Siok Wan Gan, Yuichiro Shimizu, Yoshinao Ruike, (unknown), Taichi Kuramochi, Masaru Muraoka, Takehisa Kitazawa, Yoshiki Kawabe, Tomoyuki Igawa, Kunihiro Hattori, Jun‐ichi Nezu	40
12	Increasing of Ternary Complex Formation By Predominant Accumulation of Factor (F)X Accompanied By Increase of Fixa Contributes to Enhancement of Clotting Function By Apcc in Combination with Emicizumab 2017 ·Blood ·Koji Yada, Keiji Nogami, Tomoko Matsumoto, Takehisa Kitazawa, Midori Shima	1
13	Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens 2017 ·Thrombosis and Haemostasis ·Takehisa Kitazawa, Keiko Esaki, Tatsuhiko Tachibana, Shinya Ishii, Tetsuhiro Soeda, Atsushi Muto, Yoshiki Kawabe, Tomoyuki Igawa, Hiroyuki Tsunoda, Keiji Nogami, Midori Shima, Kunihiro Hattori	152
14	Anti‐factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation 2013 ·Journal of Thrombosis and Haemostasis ·(unknown), Kazutaka Yoshihashi, Minako Takeda, Takehisa Kitazawa, Tetsuhiro Soeda, Tomoyuki Igawa, Yoshihiro Sakamoto, Kenta Haraya, Yoshiki Kawabe, Midori Shima, Akira Yoshioka, Kunihiro Hattori	114
15	Inhibition of factor XI reduces thrombus formation in rabbit jugular vein under endothelial denudation and/or blood stasis 2010 ·Thrombosis Research ·(unknown), Atsushi Yamashita, Sayaka Moriguchi‐Goto, Chihiro Sugita, Tomoko Matsumoto, (unknown), Yuichiro Sato, Takehisa Kitazawa, Kunihiro Hattori, Midori Shima, Yujiro Asada	29
16	Factor VIII contributes to platelet-fibrin thrombus formation via thrombin generation under low shear conditions 2009 ·Thrombosis Research ·Chihiro Sugita, Atsushi Yamashita, Sayaka Moriguchi‐Goto, Eiji Furukoji, (unknown), Aya Harada, Tetsuhiro Soeda, Takehisa Kitazawa, Kunihiro Hattori, Shozo Tamura, Yujiro Asada	22
17	Factor VIIa inhibitors: Target hopping in the serine protease family using X-ray structure determination 2008 ·Bioorganic & Medicinal Chemistry Letters ·Takuya Shiraishi, Shojiro Kadono, Masayuki Haramura, (unknown), Yoshiyuki Ono, Hitoshi Iikura, (unknown), (unknown), Kunihiro Hattori, Yoshiaki Watanabe, Akihisa Sakamoto, Kazutaka Yoshihashi, Takehisa Kitazawa, Keiko Esaki, Masateru Ohta, Haruhiko Sato, (unknown)	12
18	Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery 2006 ·Journal of Thrombosis and Haemostasis ·Atsushi Yamashita, Kensaku Nishihira, Takehisa Kitazawa, Kazutaka Yoshihashi, Tetsuhiro Soeda, Kazuki Esaki, Takuroh Imamura, Kunihiro Hattori, Yujiro Asada	74
19	Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitor 2004 ·Biochemical and Biophysical Research Communications ·Shojiro Kadono, Akihisa Sakamoto, Yasufumi Kikuchi, Masayoshi Oh‐eda, (unknown), Kazutaka Yoshihashi, Takehisa Kitazawa, Tsukasa Suzuki, (unknown), Kunihiro Hattori, Takuya Shiraishi, Masayuki Haramura, (unknown), Yoshiyuki Ono, (unknown), Haruhiko Sato, Yoshiaki Watanabe, Susumu Itoh, Masateru Ohta, (unknown)	5
20	Calcium ion in cardiac contractility. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·S Ebashi, Takehisa Kitazawa, Kazuhiro Kohama, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact